Monte Rosa Therapeutics (GLUE) Other Gross PP&E Adjustments (2023 - 2025)
Monte Rosa Therapeutics (GLUE) has 3 years of Other Gross PP&E Adjustments data on record, last reported at $28.1 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 25.36% year-over-year to $28.1 million; the TTM value through Sep 2025 reached $28.1 million, up 25.36%, while the annual FY2024 figure was $23.0 million, 33.51% up from the prior year.
- Other Gross PP&E Adjustments reached $28.1 million in Q3 2025 per GLUE's latest filing, up from $26.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $28.1 million in Q3 2025 and bottomed at $13.5 million in Q2 2023.
- Average Other Gross PP&E Adjustments over 3 years is $20.7 million, with a median of $21.6 million recorded in 2024.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 59.21% in 2024, then increased 23.4% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at $17.2 million in 2023, then soared by 33.51% to $23.0 million in 2024, then increased by 21.9% to $28.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $28.1 million in Q3 2025, $26.8 million in Q2 2025, and $24.4 million in Q1 2025.